FDA Leadership Changes

News

FDA Appoints Biotech Exec

FDA Names Former Pharmaceutical Executive To Oversee U.S. Drug Program

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs.

· 3d

Makary ally named to key FDA drug post

· 4d

FDA Appoints Biotech Exec as Top Drug Regulator

Science-Based Medicine1dOpinion

FDA Has Replaced its Leadership With Doctors Who Have Done Their “Research”

A large tertiary care center in Sydney, Australia is pulling out all the stops to try and cut their expenses. As of next ...

Fierce Pharma11d

Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues

The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...

JD Supra1mon

Staying Prepared Amid FDA Changes | Gardner Law - JDSupra

Despite recent staffing reductions and leadership transitions at the FDA, pharmaceutical and medical device manufacturers should not interpret these changes as a signal of reduced regulatory ...

foxbaltimore1mon

FDA announces sweeping changes to Drug Review process - WBFF

WASHINGTON (TNND) — The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10-12 months ...

Seattle Times2mon

WA vaccine scientists push back against FDA changes around COVID shots

WA vaccine scientists push back against FDA changes around COVID shots . May 21, 2025 at 6:00 am Updated May 21, 2025 at 6:01 am . By . Elise Takahama. Seattle Times staff reporter.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results